These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3481627)

  • 1. Bactericidal effect of ofloxacin alone and combined with fosfomycin or vancomycin against Staphylococcus aureus in vitro and in sera from volunteers.
    Weber P; Boussougant Y; Ichou F; Dutoit C; Carbon C
    J Antimicrob Chemother; 1987 Dec; 20(6):839-47. PubMed ID: 3481627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative bactericidal kinetics of ciprofloxacin, ofloxacin and pefloxacin alone and in combination against strains of group D Streptococcus].
    Zuccarelli M; Simeon de Buochberg M; Maillols M; Armynot du Chatelet AM; Attisso MA
    Pathol Biol (Paris); 1988 May; 36(5):403-9. PubMed ID: 3136422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of fosfomycin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
    Pistella E; Falcone M; Baiocchi P; Pompeo ME; Pierciaccante A; Penni A; Venditti M
    Infez Med; 2005 Jun; 13(2):97-102. PubMed ID: 16220029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The microbiological efficacy of the combination of fosfomycin and vancomycin against clinically relevant staphylococci.
    Gatermann S; Schulz E; Marre R
    Infection; 1989; 17(1):35-7. PubMed ID: 2921087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of fosfomycin in combination with various antistaphylococcal substances.
    Grif K; Dierich MP; Pfaller K; Miglioli PA; Allerberger F
    J Antimicrob Chemother; 2001 Aug; 48(2):209-17. PubMed ID: 11481290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of fosfomycin and teicoplanin in serum bactericidal activity against staphylococci.
    Vogt K; Rauhut A; Trautmann M; Hahn H
    Arzneimittelforschung; 1995 Aug; 45(8):894-7. PubMed ID: 7575756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus.
    Sahuquillo Arce JM; Colombo Gainza E; Gil Brusola A; Ortiz Estévez R; Cantón E; Gobernado M
    Rev Esp Quimioter; 2006 Sep; 19(3):252-7. PubMed ID: 17099793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bactericidal activity and killing rate of serum in volunteers receiving vancomycin or teicoplanin with and without amikacin given intravenously.
    Van der Auwera P; Klastersky J
    J Antimicrob Chemother; 1987 May; 19(5):623-35. PubMed ID: 2956228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of coumermycin, ofloxacin and vancomycin against methicillin-resistant Staphylococcus aureus in vitro and in experimental infections of mice.
    Hirschl AM; Georgopoulos A; Stanek G; Breyer S; Rotter ML
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Mar; 267(4):541-8. PubMed ID: 3164157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of combined vancomycin and fosfomycin against methicillin-resistant Staphylococcus aureus in biofilms in vivo.
    Shi J; Mao NF; Wang L; Zhang HB; Chen Q; Liu H; Tang X; Jin T; Zhu CT; Li FB; Sun LH; Xu XM; Xu YQ
    PLoS One; 2014; 9(12):e113133. PubMed ID: 25551618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae.
    Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Viladrich PF; Gudiol F
    J Antimicrob Chemother; 2006 May; 57(5):931-6. PubMed ID: 16507562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of antimicrobial effects of various antibiotics against methicillin-resistant Staphylococcus aureus (MRSA) by combination with fosfomycin.
    Nakazawa H; Kikuchi Y; Honda T; Isago T; Nozaki M
    J Infect Chemother; 2003 Dec; 9(4):304-9. PubMed ID: 14691650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular bactericidal activity of fosfomycin against staphylococci: a comparison with other antibiotics.
    Trautmann M; Meincke C; Vogt K; Ruhnke M; Lajous-Petter AM
    Infection; 1992; 20(6):350-4. PubMed ID: 1293056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Post-antibiotic effect of ciprofloxacin alone and in combination on Streptococcus faecalis].
    Zuccarelli M; Simeon de Buochberg M; Maillols H; Dusart G; Attisso MA
    Pathol Biol (Paris); 1988 May; 36(5):410-3. PubMed ID: 3136423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of fosfomycin combined with rifampin, pefloxacin and imipenem against staphylococci: a study by the time-kill curve method.
    Quentin C; Saivin S; Lafferriere C; Noury P; Bebear C
    Drugs Exp Clin Res; 1987; 13(4):219-24. PubMed ID: 3476291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro efficacy of antimicrobial agents against high-inoculum or biofilm-embedded meticillin-resistant Staphylococcus aureus with vancomycin minimal inhibitory concentrations equal to 2 μg/mL (VA2-MRSA).
    Tang HJ; Chen CC; Ko WC; Yu WL; Chiang SR; Chuang YC
    Int J Antimicrob Agents; 2011 Jul; 38(1):46-51. PubMed ID: 21549575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo study of serum bactericidal titers and killing rates of daptomycin (LY146032) combined or not combined with amikacin compared with those of vancomycin.
    Van der Auwera P
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1783-90. PubMed ID: 2556079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fosfomycin plus β-Lactams as Synergistic Bactericidal Combinations for Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus.
    del Río A; García-de-la-Mària C; Entenza JM; Gasch O; Armero Y; Soy D; Mestres CA; Pericás JM; Falces C; Ninot S; Almela M; Cervera C; Gatell JM; Moreno A; Moreillon P; Marco F; Miró JM;
    Antimicrob Agents Chemother; 2016 Jan; 60(1):478-86. PubMed ID: 26525803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro study of the cefamandole-fosfomycin combination against methicillin-resistant staphylococci].
    Fosse T; David MF; Duluc F; Darmusey D; Tamalet C; Toga B
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):528-31. PubMed ID: 6462742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum bactericidal activity against Enterobacteriaceae producing broad-spectrum beta-lactamases in volunteers administered ofloxacin and cefotaxime, alone or combined.
    Weber P; Boussougant Y; Farinotti R; Carbon C
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):524-6. PubMed ID: 2504593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.